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ABST RACT
Objectives. Basal cell carcinomas (BCCs) are malignant tumors which rarely
metastasize, are slow-growing, and extensively locally destructive. BCCs
more than 5 cm in diameter are defined as giant. Most often they arise as a
result of neglect, as the patient avoids, delays, or refuses to see a doctor. The
large tumor diameter and consequently of the post-excisional defect make
these lesions difficult to treat surgically with respect to selecting the surgical
reconstruction technique. Method. We studied a group of 9 patients, aged 60
to 85 years, diagnosed with giant basal cell carcinomas (GBCCs) with
periocular location in which surgery was indicated. Results. In all cases,
complete excision with histologically clear margins was performed and for
the coverage of the remaining defect various, complex, and sometimes twostage reconstructive techniques were used. Conclusions. Giant cell
carcinoma of the periocular region requires extensive and risky surgery,
especially when performed on the elderly. Early referral to a doctor avoids
all these risks, in all cases the pathological diagnosis was nodular BCCs. The
aesthetic and functional outcomes were good to very good, and the patients
reported being highly satisfied.

Introduction
Although it represents only a small percentage of the
body surface area, approximately 5 to 10 percent of all skin
cancers occur in the periocular region [1]. Basal cell
carcinomas (BCCs) account for 90% of malignant eyelid
tumors, being the most common type of skin cancer in
Europe, Africa, and North America [2]. BCCs are most
commonly located on areas with prolonged exposure to
solar ultraviolet radiation, which is the main risk factor,
and confirmation of BCCs diagnosis is a negative
prognostic factor for the development of other associated
skin lesions [3]. Usually, these malignant tumors are slowgrowing, rarely metastasize, but have a significant local
destructive potential [4]. However, BCCs may present a
rare but aggressive biological variant, named giant basal
cell carcinomas (GBCCs) defined as BCCs with a diameter
of 5 cm or more characterized by deep tissue invasion,
rapid growth and high risk of metastasis, increased rate of
local complications, and poor prognosis [5,6]. GBCCs
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account for 0.4%-1% of all BCCs [7]. The pathogenesis of
GBCCs is sometimes linked to a spontaneous mutation in
the human patch gene (PTCH), mapped to the q22.33 locus
of chromosome 9; however, over 30% of GBCCs cases are
due to the delay in seeking medical attention, most often
associated to mental deficiency, low socioeconomic status,
poor hygiene, advanced age, or the fact that BCCs are
painless [8]. Although mortality is low, the morbidity
caused by this tumor is significant due to its locally
invasive and relapse potential [9,10]. The metastatic
potential of BCCs is estimated to be less than 0.03%, while
GBCCs have a higher rate of metastasis [11]. It is reported
that systemic metastases predominantly occur in giant
GBCCs exceeding 100 cm2 in surface area or 25 cm in
diameter [12]. Surgical excision is highly effective, being
the preferred treatment option over time. BCCs should be
excised with 3-4 mm safety margins from the adjacent
macroscopically healthy tissue to exclude microscopic
invasion of neoplastic cells. Recurrences at the operative
site, especially periorbital, perinasal, and periauricular,
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should be treated with great caution; thus, re-excision
should be carried out early as it has been found that a high
number of BCCs relapse to become much more aggressive
[13]. The current study includes a group of 9 patients with
nodular BCCsover 5 cm in diameter and different
periocular locations. In all cases, excision with adequate
margins was performed. Given the large size of the tumors
as well as of the soft-tissue defects after tumor excision,
different reconstruction techniques were used, most often
of great complexity, in some cases even two-stage.

Materials and Methods
The current study includes a group of 9 patients, 8 men
and one woman, aged 60 to 85 years, who presented to the
Clinic of Plastic Surgery and Reconstructive Microsurgery,
St. Spiridon Emergency Hospital Iasi, between January
2017 and July 2018. All patients presented on admission
ulcerative lesions, bleeding in 3 cases in the periocular
region. In 4 cases the tumor masses were located at the
external angle of the right eye, in 2 cases on the lower
eyelid, in 2 cases at the external angle of the left eye, and
in one case in the glabellar region with extension to the
inner angles of both eyes (Figure1). These lesions ranged
from 5 to 7.5 cm in diameter, which defines them as
"giant", and were present for 5 to 12 years.

intubation and consisted of the surgical removal of the
masses with adequate surgical margins (Figure 2).

Figure 2. (A) surgical removal of the tumoral
masses with adequate surgical margins with bone
extension, including periocular fat. (B) wide
excision of the giant cell carcinoma of the glabellar
region. (C) wide excision of the giant cell
carcinoma of the lower eyelid.
As all patients were aged over 60, the preoperative
preparation was done in collaboration with the cardiologist
and anesthesiologist. Coverage of post-excisional softtissue defects required complex and varied reconstruction
techniques. Three of the cases required two-stage
reconstruction. The Mustard-type flap, the forehead and
genian flap techniques (Fricke flap in one case), and
advancement genian flap, of which one anchored to the
zygomatic bone, were used in 3 cases each. In three cases,
eyeball protection required its coverage with a conjunctival
flap that was sectioned three months postoperatively, and
the eyes reopened (Figure 3).

Figure 1. (A) the external angle of the right eye. (B) the
glabellar region with extension to the inner angles of
both eyes. (C) the lower eyelid.
Physical examination on admission made a
presumptive diagnosis of ulcerated GBCCs carcinoma
based on the macroscopic appearance, location, and size of
the lesions, highly suggestive for this type of neoplasm, as
well as on case history that revealed slow growth over a
long period of time. Patients were informed about the
procedures to be undergone and informed consent was
obtained from all study patients. Preoperative imaging
explorations consisted of computer tomography (CT)
examination to determine the degree of tumor invasion of
the eyeball and its appendages. In all cases, tumor invasion
of the eyeball was absent, the reason why the indication for
exenteration was excluded with the agreement and in
collaboration with the eye surgeon. In all cases, surgery
was performed under general anesthesia with endotracheal
228

Figure 3. (A) Mustarde- flap. (B) the coverage of
the tissue defect with Mustarde flap. (C) eyeball
protection with a conjunctival flapwith eye closed.
(D) association between forhead and genian flap.
(E) coverage of the soft tissue postexcisional defect
with a Mustarde flap.

Results
The immediate postoperative course was favorable in
all study cases. In only one case did we find distal venous
congestion of the flap with a necrotic zone. To cover the
lower eyelid soft tissue defect resulting from necrectomy,
a split-thickness skin graft was performed 14 days after
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surgery. The postoperative edema, ecchymoses, and
erythema disappeared completely after 4-6 weeks, and the
end result (functional and esthetic) was assessed
approximately 3 - 6 months postoperatively (Figure 4).

Long-term course was good, with complete flap reintegration and healing of donor area, without pathological
scars. The results were assessed from a functional point of
view (eyelids), color, and texture of flaps, as well as the
appearance and esthetic impact of the scars, taking into
account the degree of patient satisfaction. All patients were
satisfied with the functional as well as the esthetic
outcomes, with no eyelid occlusion disturbances that could
possibly affect the visual function. No less important was
the psychological improvement and the rapid social
reintegration of these patients, although most of them were
retired. The histopathological examinations confirmed the
excision of the masses within the oncological limits in all
the plans, and clinically no recurrences were found 18
months postoperatively.

Discussions

Figure 4. A,B,C,D,E: functional and aesthetic good
results in all cases.
The diagnosis of certainty was made by the
histopathological examination which revealed in all
casesand ulcerated nodular BCCs (Figure 5).

Figure 5. (A) Nodular basal cell carcinoma ulcerated
with fibrin-leukocyte exudate on the surface. Tumor cell
nests with microcystic dilatations, associating reduced
desmoplasticstroma (x5 H&E staining). (B) Nodular
basal cell carcinoma tumor islands of various dimensions,
having artefactual cleavage space with adjacent tumor
stroma (x10 H&E staining). (C) Nodular basal cell
carcinoma with tumor nodules of different sizes and
shapes. Area of ulceration on the surface with fibrinleukocyte debris (x5 H&E staining).

The indication for adjuvant radio-chemotherapy was
subsequently established by the oncologist. In all cases
the excision was performed with histologically clear
margins (safety margins), re-excision not being needed
in any of these cases.

GBCCs are rarely reported in the literature, being a rare
oncologic entity. In the TNM classification, they are
designated T3 [14]. In a study of 17 cases diagnosed with
GBCCs, Maimaiti et al. reported an 11/6 male
predominance, while another study by Shuo Fang et al.
from the Plastic and Reconstructive Surgery Clinic of
Shanghai Hospital, China showed a 9/6 male
predominance. In our study, we found a higher male
predominance, namely 8/1. In the literature, no concrete
causes for this higher incidence in men are reported. It is
believed that a possible explanation may be the
involvement of men in jobs with prolonged exposure to
ultra violet radiation, associated with a possible higher
degree of neglect or alcohol consumption. Mean age at the
time of GBCCs diagnosis is about 67 years [15,16]. In our
study group the mean age was 72.2 years.
The socio-economic status of the patients is considered
to be a major risk factor. As all the patients included in this
study resided in rural areas, living in precarious conditions
and having difficulties in accessing healthcare could be
considered factors that may have contributed to their late
presentation (after 5 to 12 years) to a specialist, findings
supported by other reports in the literature [8]. Old age is
another important risk factor demonstrated by the current
study, the youngest patient in our study group being aged
60 and the oldest 85 [9]. Given the patients’ age, possible
mental deficiencies should not be excluded. All 9 patients
included in this study reported that they did not experience
pain throughout tumor development. However, Randle et
al. reported that GBCCs have a greater propensity to
metastasize, especially when they reach critical dimensions
of over 10 cm, and Archontaki et al.found a 17.6%
incidence of metastases at the time of presentation based
on the review of the published literature until that time (30
articles, 51 patients); fortunately, in our study group no
metastases were identified at the time of presentation or
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during postoperative follow-up [6, 14]. GBCCs show a
predilection for lymph node metastasis, but also possible is
the hematogenous spread with metastases to the
parenchymal internal organs or bone metastases, which
causes anemia by replacement of the hematopoietic
marrow or secondary amyloidosis of the kidney, spleen, or
intestines, which would considerably worsen the prognosis
[17-19].
Key to successful treatment of periocular GBCCs
appears to be radical surgical excision, even if it requires
the removal of important eyelid anatomic elements and
causes large soft-tissue defects that require laborious
reconstruction methods [20]. In most small BCCs, the 24mm safety margins provide adequate excision, but
GBCCs have a higher incidence of subclinical extension
requiring excisions with 3-5mm safety margins. The
periocular area is of major functional and esthetic
importance, which is why it requires special attention,
especially when it comes to the defects post-excision of a
GCBCs, where direct suture would give unsatisfactory
results due to the resulting tension on ocular adnexa [21].
The methods for the reconstruction of post-excisional
defects in the periocular area require the knowledge and
respect of some principles related to the use of flaps and
skin grafts that offer safer and more efficient solutions, the
flaps being preferred over the grafts in this anatomical
region because their homogeneity in color and texture will
lead to a better esthetic, functional, and morphological
unification with the surrounding tissues. In addition, free
skin plasty cannot be used when the excision reveals
slightly vascularized anatomical elements, blood vessels,
or nerves [22]. Often, negative pressure therapy cannot be
used to obtained a real granular bed for split skin grafting.
In order to use negative pressure therapy, we must have the
certainty of a complete excision of the tumor [23]. Locoregional flaps had been used for the reconstruction of
defects in all 9 study patients, the obtained being reported
above.
Radiation therapy may have an adjuvant or palliative
role in GBCCs, especially in patients with extensive facial
lesions or altered general conditions that would not tolerate
such an extensive surgery, but the response to this type of
treatment is heterogeneous and difficult to predict. There
appears to be no correlation between tumor location and
the type of response to radiation therapy, but the nodular
subtype of BCCs is considered to respond well to radiation
therapy, and the sclerosing BCCs is described as having a
high recurrence rate after radiation therapy [18, 24]. It
should be mentioned there is high operative risk for these
patients who are often elderly and in which no other form
of local anesthesia can be used [25]. The localization of
these large tumors of the face is a real challenge in
choosing the surgical technique, being much more difficult
than in other anatomical regions of the body [26, 27].
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Vismodegib is a new treatment option, the only
medication approved by the US Food and Drug
Administration in 2012 for the treatment of locally
advanced or metastatic BCCs. In 54% of the patients
receiving Vismodegib treatment, the absence of residual
disease in control biopsies was confirmed. The average
duration of treatment is 7.6 months, and the common side
effects are muscle spasms, dysgeusia, alopecia, and weight
loss. This therapeutic option may be a good alternative in
patients with contraindications for surgery or metastases
[28].

Conclusions
Early detection of BCCs and radical surgical treatment
are probably the most effective weapon against the
development of a GBCCs. This could be achieved by
improving the primary health care services and
encouraging patients to undergo surgery at earlier stages of
the disease, as well as educating them with regard to the
course of this disease. Regarding the surgical treatment of
periocular GBCCs, tumor resection should be done with
safety margins. Reconstruction of post-excisional defects
can be performed with local flaps, which is a safe method
that provides good functional and esthetic outcomes, as
confirmed by the results of this study. Absence of tumor
invasion in the resection margins must be confirmed by
histopathological examination. Given the high relapse rate,
a long-term follow-up of these patients is required.
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